The previous study reported that CD14 and TLR2 were upregulated in animal models of various neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and ALS [30]. This evidence concerns the gene TLR2 and neurodegenerative disease.